Literature DB >> 12226754

The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.

Qiang G Dong1, Guido M Sclabas, Shuichi Fujioka, Christian Schmidt, Bailu Peng, TianAi Wu, Ming-Sound Tsao, Douglas B Evans, James L Abbruzzese, Timothy J McDonnell, Paul J Chiao.   

Abstract

The Rel/NF-kappaB transcription factors play a key role in the regulation of apoptosis and in tumorigenesis by controlling the expressions of specific genes. To determine the role of the constitutive activity of RelA in tumorigenesis, we generated pancreatic tumor cell lines that express a dominant negative mutant of IkappaBalpha (IkappaBalphaM). In this report, we show that the inhibition of constitutive NF-kappaB activity, either by ectopic expression of IkappaBalphaM or by treating the cells with a proteasome inhibitor PS-341 which blocks intracellular degradation of IkappaBalpha proteins, downregulates the expression of bcl-xl. We identified two putative NF-kappaB binding sites (kappaB/A and B) in the bcl-xl promoter and found that these two sites interact with different NF-kappaB proteins. p65/p50 heterodimer interacts with kappaB/A site whereas p50/p50 homodimer interacts with kappaB/B. The bcl-xl promoter reporter gene assays reveal that NF-kappaB dependent transcriptional activation is mainly mediated by kappaB/A site, indicating that bcl-xl is one of the downstream target genes regulated by RelA/p50. Both IkappaBalphaM and PS-341 completely abolish NF-kappaB DNA binding activity; however, PS-341, but not ectopic expression of IkappaBalphaM, sensitized cells to apoptosis induced by Taxol. This is due to the Taxol-mediated reactivation of RelA through phosphorylation and degradation of IkappaBbeta and the re-expression of NF-kappaB regulated bcl-xl gene in these cancer cells as ectopic expression of the bcl-xl gene confers resistance to Taxol-induced apoptosis in PS-341 sensitized cells. These results demonstrate the important function of various NF-kappaB/IkappaB complexes in regulating anti-apoptotic genes in response to apoptotic stimuli, and they raise the possibility that NF-kappaB : IkappaBalpha and NF-kappaB : IkappaBbeta complexes are regulated by different upstream activators, and that NF-kappaB plays a key role in pancreatic tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226754     DOI: 10.1038/sj.onc.1205848

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

Review 1.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.

Authors:  Soukaina Réjiba; Christelle Bigand; Céline Parmentier; Amor Hajri
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  Effects of IkappaBalpha and its mutants on NF-kappaB and p53 signaling pathways.

Authors:  Xian Li; Da Xing; Ju Wang; De-Bin Zhu; Lan Zhang; Xiao-Jia Chen; Fen-Yong Sun; An Hong
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

5.  Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer.

Authors:  Nkechi Ichite; Mahavir B Chougule; Tanise Jackson; Suniket V Fulzele; Stephen Safe; Mandip Singh
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

6.  Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma.

Authors:  Natini Jinawath; Chanont Vasoontara; Artit Jinawath; Xueping Fang; Kejia Zhao; Kai-Lee Yap; Tong Guo; Cheng S Lee; Weijie Wang; Brian M Balgley; Ben Davidson; Tian-Li Wang; Ie-Ming Shih
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

7.  α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model.

Authors:  Bilal Bin Hafeez; Ala Mustafa; Joseph W Fischer; Ashok Singh; Weixiong Zhong; Mohammed Ozair Shekhani; Louise Meske; Thomas Havighurst; KyungMann Kim; Ajit Kumar Verma
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

8.  Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway.

Authors:  Jin Xia; Feng Wang; Liuxing Wang; Qingxia Fan
Journal:  Tumour Biol       Date:  2012-10-19

9.  NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.

Authors:  Shuichi Fujioka; Jiangong Niu; Christian Schmidt; Guido M Sclabas; Bailu Peng; Tadashi Uwagawa; Zhongkui Li; Douglas B Evans; James L Abbruzzese; Paul J Chiao
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo.

Authors:  Annika Lehmann; Carsten Denkert; Jan Budczies; Ann-Christin Buckendahl; Silvia Darb-Esfahani; Aurelia Noske; Berit Maria Müller; Marcus Bahra; Peter Neuhaus; Manfred Dietel; Glen Kristiansen; Wilko Weichert
Journal:  BMC Cancer       Date:  2009-11-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.